Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

This post was originally published on this site

Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells based on their genetics.

Its technology targets solid tumors based on a patented lipid nanoparticle gene delivery system and a highly targeted DNA payload. The Seattle-based company just extended

contactedorg

Check out http://contacted.org